drugset / Trial / NCT00114504

Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation

NCT00114504

Completed 43 enrolled Kurume University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether FDG-PET is capable of detecting atherosclerotic plaque inflammation and monitoring the effects of statins on plaque inflammation. The usefulness of FDG-PET in risk stratification is also investigated.

Timeline

Start
2004-09
Primary completion
2007-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 5 mg
Subject Simvastatin Small molecule 10 mg

Indications